These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 10440208)

  • 1. A selective cyclo-oxygenase-2 inhibitor, NS-398, may improve portal hypertension without inducing gastric mucosal injury.
    Tsugawa K; Hashizume M; Migou S; Kishihara F; Kawanaka H; Tomikawa M; Sugimachi K
    J Gastroenterol Hepatol; 1999 Jul; 14(7):642-51. PubMed ID: 10440208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation.
    Hou MC; Cahill PA; Zhang S; Wang YN; Hendrickson RJ; Redmond EM; Sitzmann JV
    Hepatology; 1998 Jan; 27(1):20-7. PubMed ID: 9425912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach.
    Maricic N; Ehrlich K; Gretzer B; Schuligoi R; Respondek M; Peskar BM
    Br J Pharmacol; 1999 Dec; 128(8):1659-66. PubMed ID: 10588920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
    Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide and endothelin-1 in a portal hypertensive rat model.
    Tsugawa K; Hashizume M; Migou S; Kishihara F; Kawanaka H; Tomikawa M; Tanoue K; Sugimachi K
    Scand J Gastroenterol; 2000 Oct; 35(10):1097-105. PubMed ID: 11099065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
    Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM
    Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins.
    Konturek PC; Brzozowski T; Konturek SJ; Taut A; Kwiecien S; Pajdo R; Sliwowski Z; Hahn EG
    Digestion; 1998; 59(4):284-97. PubMed ID: 9693198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclo-oxygenase-2 inhibitors suppress epithelial cell kinetics and delay gastric wound healing in rats.
    Sun WH; Tsuji S; Tsujii M; Gunawan ES; Sawaoka H; Kawai N; Iijima H; Kimura A; Kakiuchi Y; Yasumaru M; Sasaki Y; Kawano S; Hori M
    J Gastroenterol Hepatol; 2000 Jul; 15(7):752-61. PubMed ID: 10937680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
    Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel role of prostacyclin in stress-induced gastric mucosal lesion formation in rats.
    Harada N; Okajima K; Murakami K; Uchiba M; Tanaka K; Okabe H; Takatsuki K
    J Lab Clin Med; 1997 Jun; 129(6):620-6. PubMed ID: 9178728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
    Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
    Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of cyclooxygenase-2 by NS-398 in endotoxin shock rats in vivo.
    Futaki N; Takahashi S; Kitagawa T; Yamakawa Y; Tanaka M; Higuchi S
    Inflamm Res; 1997 Dec; 46(12):496-502. PubMed ID: 9459080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.
    Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG
    Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective cyclooxygenase (COX) inhibition causes damage to portal hypertensive gastric mucosa: roles of nitric oxide and NF-kappaB.
    Akahoshi T; Tanigawa T; Sarfeh IJ; Chiou SK; Hashizume M; Maehara Y; Jones MK
    FASEB J; 2005 Jul; 19(9):1163-5. PubMed ID: 15845610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension.
    Eizayaga FX; Aguejouf O; Desplat V; Belon P; Doutremepuich C
    World J Gastroenterol; 2007 Oct; 13(38):5065-70. PubMed ID: 17876871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.